PDA BioManufacturing Conference 2024 | Parenteral Drug Association | 23 September 2024 | Elite Park Avenue Hotel Gothenburg, Kungsportsavenyen 36, 411 36 Göteborg, Sweden

As global health challenges like infectious diseases and cancer evolve, the pharmaceutical biomanufacturing sector continues to innovate and adapt. This industry's advancements attract significant interest from investors, regulators, and other stakeholders, underscoring the importance of staying informed about the latest developments.

The event will explore new technologies including the application of AI, digital twins, development approaches, CMC strategies, and regulatory frameworks, supporting rapid access to vaccines and biotherapeutics from upstream processes to final filling and lyophilization.

This event themed "Shaping the Future of Biomanufacturing", is the ideal venue for exploring these innovations. Now in its sixth year, this event offers a comprehensive program focused on emerging trends, regulatory areas, and key technologies.

We are kicking off this year’s conference with a keynote presentation from a patient perspective and we will continue the discussion on addressing patient needs and offer unique networking opportunities with industry professionals, academics, and regulatory representatives from organizations like the U.S. FDA, MHRA, Medical Products Agency Sweden, Paul-Ehrlich-Institut, EDQM, and CEPI.

Session highlights will feature case studies, expert views on biopharmaceutical innovations, advanced modeling, manufacturing capacity, and sustainability as well as special attention will be given to new regulatory strategies for sustainability reporting.

2024 Speakers

Adithya Balasubramanian
Director, ten23 health AG

Bianca Bohrer, Dipl Ing
Managing Director, PSM GmbH

Anthony Cannon

Cristiana Campa, PhD
Technical R&D Advisor and Senior Fellow, GSK

Michael R De Felippis, PhD
Senior Vice President - Research Bioproduct Research and Development, Eli Lilly and Company

Sebastian Groel

Virginie Le Coent

Yves Mayeresse
Director, GSK

Mic McGoldrick
Technical Advocacy and Policy - CMC, Merck Sharp & Dohme Corp. LLC

Sabine Hauck, Dr
EVP Corporate Development & QM, Leukocare AG

Elisabeth Vachette, MA
BPS Sustainability Business Partner, Sartorius Stedim FMT SAS

PANELIST/PRESENTER:

Dilara Ali, MSc
PhD Student, ten23 health

Andrea Arsiccio, PhD
Senior Scientist, Coriolis Pharma

Colette Carmody Culhane, MSc
Senior Advisor, Manufacturing Science and Technology, Eli Lilly & Company

Emmanuelle F Charton
Head of Division B, European Pharmacopoeia Department, EDQM

Anna Czwarno, Ms.Eng.
Regulatory, Manufacturing & Supply Director, Vaccines Europe

Thomas De Beer, PhD
Professor, Ghent University

Jeff Gensler, MBA
Vice President - Quality, Kindeva Drug Delivery

Navdip Ghai
Director - Regulatory Affairs CMC, Merck Sharpe & Dohme

Steffen Gross
Head Section Quality and Non-clinical Evaluation of Antibody Therapeutics, Paul-Ehrlich-Institute

Armin Hauk, PhD
Principal Scientist, Sartorius Biotech GmbH

Atanas Koulov, PhD
Chief Scientific Officer, Clear Solutions Laboratories AG

Julian H. Lenger, PhD
Head of Laboratory Parenteral Drug Development, Bayer AG

Robin Levis
CBER, U.S. FDA

Peter J. Makowenskyj, MEng
Director of Design Consulting, G-CON

Toni Manzano
Co-Founder and CSO of Aizon, and Team Leader, AI in Operations (AIO), Aizon and United Nations, professor at the URV

Paul Matejtschuk, PhD FRSC CChem
Section Head Formulation Science, MHRA

Roman Mathaes, PhD
CEO, Clear Solutions Laboratories

Frédéric Mathot, PhD
Associate Director, Scientific Leader, GSK

Ina Pahl
Senior Scientist, Sartorius Stedim Biotech GmbH

Maria Papathanasiou, PhD
Associate Professor (UK Senior Lecturer), Department of Chemical Engineering, Imperial College London

Mónica Perea-Vélez, MSc, PhD
CMC Advocacy and Policy Director, GSK

Fabian Plaum, M.Eng.
Sales Management, HOF Sonderanlagenbau GmbH

Durga Prasad Madhavapeddi

Sabrina Restrepo, PhD
Director, Vaccines - Technical Product Leadership, Merck & Co., Inc.

Olga Rovira
Regulatory Affairs Senior Consultant, CEPI

Ramin Sabet-Azad, PhD
CMC Lead, The Coalition for Epidemic Preparedness Innovations (CEPI)

Sebastian Scheler, Mr.
Managing Director, Innerspace GmbH

Karen Somers

Christian Sonntag, MS
Senior Project Manager, Roche Diagnostics GmbH

Thomas Stangler

Matthias Steiger

Elisabeth Vachette, MA
BPS Sustainability Business Partner, Sartorius Stedim FMT SAS

Jason Warfel

Mats Welin

Thomas Zahel, PhD
Head of Innovation, Körber Pharma

Pepijn Burgers

Philippe Gadal

Thomas Kriehuber

2024 Sponsors

• Asahi Kasei

PLATINUM:
• Korber